4-Hydroxybenzothioamide

We are 4-Hydroxybenzothioamide CAS:25984-63-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-Hydroxybenzothioamide
CAS.NO:25984-63-8
Synonyms:4-Hydroxybenzothioamide
4-[amino(sulfanyl)methylidene]cyclohexa-2,5-dien-1-one
4-Hydroxybenzenecarbothioamide
4-Hydroxybenzene-1-carbothioamide
4-(aminothioxomethyl)phenol
BENZENECARBOTHIOAMIDE,4-HYDROXY
p-hydroxybenzothiomide
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 320.4±44.0 °C at 760 mmHg
Molecular Formula C7H7NOS
Molecular Weight 153.202
Flash Point 147.6±28.4 °C
 
Specification:
Appearance:Light yellow powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Febuxostat(CAS:144060-53-7).

4-Hydroxybenzothioamide


Related News: The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.4-Fluoroacetophenone Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.trans-N,N'-dimethylcyclohexane-1,2-diamine Beta Bionics, Inc. recently announced it has received Breakthrough Device designation from the US FDA for its investigational iLet Bionic Pancreas System.767-15-7 With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.With nearly 194 billion US dollars of original research medicines facing the expiration of patents in the past five years, more and more domestic companies are focusing on the corresponding characteristic APIs, and have started research and development and production preparations in advance. The scale of production and export of APIs will continue to expand and grow.

Related Products
Product Name
Methyl 3-carbamimidamido-4-methylbenzoate nitrate (1:1) View Details
1-CHLORO-6-IODOHEXANE View Details
4-Bromo-4′-iodo-1,1′-biphenyl View Details
(S)-1,2,3,4-Tetrahydro-1-Naphthoic Acid manufacturer 4-tert-Butylphenylboronic acid manufacturer 3-Bromo-2-chloro-5-methylpyridine manufacturer Dodecyl 2-methylacrylate manufacturer 1-isothiocyanato-4-nitrobenzene manufacturer